Warner Douglas J 4
4 · Tyra Biosciences, Inc. · Filed Sep 10, 2024
Insider Transaction Report
Form 4
Warner Douglas J
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-09-09+260,000→ 260,000 totalExercise: $21.51Exp: 2034-09-08→ Common Stock (260,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on September 9, 2025, and 1/36th of the remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.